Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IV Iron in Anemic Colon Cancer Patients
NCT04653181Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Postoperative complications at 30 days. Started Oct 2020; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04653181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04653181.